NCT04125693 2022-04-01Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its SafetyBayerPhase 2 Completed1 enrolled
NCT01928459 2020-12-09Phase 1b Trial of BGJ398/BYL719 in Solid TumorsNovartisPhase 1 Completed62 enrolled